Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

0.390
+0.0154.00%
Volume:85.00K
Turnover:32.78K
Market Cap:241.02M
PE:-0.80
High:0.390
Open:0.375
Low:0.375
Close:0.375
52wk High:5.830
52wk Low:0.330
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:0.83
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.490
ROE:-242.61%
ROA:-20.57%
PB:-2.47
PE(LYR):-0.80
PS:- -

Loading ...

Over 550 Drugs Pass Initial Review for National Reimbursement, Sparking Rally in Innovative Drug Sector

Deep News
·
Jun 30

Innovative Drug Sector Surges with Limit-Ups, ETF Leadership, and Doubled Turnover: Has the Bitter Phase Finally Ended?

Deep News
·
Jun 29

Innovative Drug Sector Stages a Comeback: Which ETF Stands Out?

Deep News
·
Jun 29

Hang Seng Index Rallies as Tech Giants and Pharma Stocks Lead the Charge

Stock News
·
Jun 29

Momentum Capital Shifts Positions, Uncovering Fresh Opportunities

Deep News
·
Jun 29

Yang Delong: The AI Era Brings New Development Opportunities for Innovative Drugs

Deep News
·
Jun 29

Hong Kong Market Rallies: Hang Seng Gains 1.57%, Biotech and Tech Sectors Lead Charge

Stock News
·
Jun 29

Hengrui's Innovative Drug Ruiming® Launches Exclusively on Alibaba Health Platform

Deep News
·
Jun 29

Pharmaceutical Stocks Surge on Policy News, Sparking Market Rally

Deep News
·
Jun 29

Seven High-Priced Innovative Drugs Poised for Price Cuts

Deep News
·
Jun 29

Innovative Drug Stocks Surge, Over 20 A-H Shares Jump More Than 10%, Drug and HK-Connect Innovative Drug ETFs See Heavy Volume and Push Towards 7% Gains, Institutions Eye Bottom Reversal

Deep News
·
Jun 29

Innovative Drug Sector Surges, Leading Market Rebound with Key ETFs and Stocks Soaring

Deep News
·
Jun 29

Anhui Wanbang Pharmaceutical to Acquire Majority Stake in CRO Firm to Enhance Innovative Drug Business

Stock News
·
Jun 26

China's Innovative Drugs Capture Nearly Half of Global Market, Unleashing Full Value of Overseas Expansion While Facing High Return Rates, Low Realization, and Homogenization Challenges

Deep News
·
Jun 26

Payouts "Shrinking"? How "Huiminbao" Navigates Pressure and Seeks Sustainable Funding

Deep News
·
Jun 25

The Health Insurance Conundrum: Balancing Affordability and Sustainability

Deep News
·
Jun 25

Private Health Insurance's Role in Funding Innovative Drugs: Bridging the Gap from Availability to Affordability

Deep News
·
Jun 25

Guosen Securities' June Pharmaceutical Sector Investment Outlook: Positive Fundamentals for Innovative Drugs and the Supply Chain

Stock News
·
Jun 25

Innovative Drug Stocks Retreat Again! Sole On-Market Pharma ETF Ends Four-Day Rally, Hong Kong Connect Innovative Drug Shares Broadly Lower, 520880 Drops Over 2.5%

Deep News
·
Jun 25

Hainanhaiyao's Novel Anti-Hepatic Fibrosis Drug Completes Phase II Trial

Stock News
·
Jun 24